Project Sage Oldco, Inc.
OTCPK:SIEN.Q Stok Raporu
Project Sage Oldco Temettüler ve Geri Alımlar
Temettü kriter kontrolleri 0/6 Project Sage Oldco şirketinin temettü ödeme geçmişi bulunmamaktadır.
Anahtar bilgiler
-4,821.7%
Geri Alım Getirisi
Toplam Hissedar Getirisi -4,821.7% Gelecekteki Temettü Verimi n/a Temettü Büyümesi n/a Bir sonraki temettü ödeme tarihi n/a Eski temettü tarihi n/a Hisse başına temettü n/a Ödeme oranı n/a
Son temettü ve geri alım güncellemeleri
Tüm güncellemeleri göster Second Amended Liquidation Plan Approved for Sientra, Inc. Jun 19
Second Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Sientra, Inc. Jun 15
First Motion for Exclusivity Period Extension Filed by Sientra, Inc. May 23
Joint Reorganization Plan and Disclosure Statement Filed by Sientra, Inc. Apr 17
Reorganization Plan and Disclosure Statement Filed by Sientra, Inc. Apr 16
The Nasdaq Stock Market to Delist the Common Stock of Sientra Apr 10
Sientra, Inc. announced delayed annual 10-K filing Mar 31 Sientra, Inc. announced delayed annual 10-K filing Mar 30
Sientra, Inc.(OTCPK:SIEN.Q) dropped from NASDAQ Composite Index Feb 22 DIP Financing Approved for Sientra, Inc. Motion for Asset Sale Filed by Sientra, Inc. Feb 15
Sientra, Inc. Filed for Bankruptcy Feb 14 Sientra, Inc. Filed for Bankruptcy
Sientra Receives Non-Compliance Notice from Nasdaq Dec 21
Consensus EPS estimates fall by 15% Nov 16
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Nov 12
New major risk - Market cap size Nov 01
Sientra, Inc. Provides Revenue Guidance for the Third Quarter of 2023 Oct 31
Sientra, Inc. Revises Earnings Guidance for the Full Year 2023 Aug 12
Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Aug 11
Sientra, Inc. to Report Q2, 2023 Results on Aug 10, 2023 Jul 28
Sientra, Inc. Appoints Alexander W. Casdin to the Company’s Board of Directors, Effective June 15, 2023 Jun 21
Sientra Announces FDA-Clearance of Next Generation Allox2 Pro Tissue Expander Jun 09
First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind May 12
Sientra, Inc. Provides Earnings Guidance for the Full Year of 2023 May 12
Fewer Investors Than Expected Jumping On Sientra, Inc. (NASDAQ:SIEN) Apr 17
Full year 2022 earnings: EPS misses analyst expectations Apr 01
Sientra, Inc. Announces Launch of Viality, Novel Fat Transfer System Dec 06
Insider recently bought US$933k worth of stock Nov 18
Price target decreased to US$2.08 Nov 16
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 16
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 13
Sientra, Inc. to Report Q3, 2022 Results on Nov 10, 2022 Nov 01 Sientra, Inc. has completed a Follow-on Equity Offering in the amount of $29.217384 million. Oct 22
Sientra slides 18% on proposes stock offering Oct 19
Sientra, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022 Oct 13
Sientra refinances convertible debt at heavy premiums, sees Q3 revenue in-line Oct 12
Sientra Receives Written Notice from the Listing Qualifications Department of Nasdaq Oct 06
Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia Sep 21
Sientra gets regulatory nod to market breast implants in Saudi Arabia Sep 20
Second quarter 2022 earnings: EPS and revenues miss analyst expectations Aug 12
Sientra, Inc. Revises Revenue Guidance for the Year 2022 Aug 12
Sientra GAAP EPS of -$0.29 misses by $0.06, revenue of $21.5M misses by $2.26M Aug 11
Sientra, Inc. to Report Q2, 2022 Results on Aug 11, 2022 Jul 29
FDA Approves Sientra’s Low Plus Profile Projection Breast Implant Jul 07
FDA approves Sientra’s breast implant product for breast augmentation, reconstruction Jul 06 Sientra, Inc.(NasdaqGS:SIEN) dropped from Russell 2000 Dynamic Index
Price target decreased to US$6.33 Jun 17
Sientra, Inc. Provides Earnings Guidance for the Year 2022 May 14
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind May 13
Price target decreased to US$6.83 May 13
Sientra, Inc. to Report Q1, 2022 Results on May 12, 2022 May 04
Sientra, Inc., Annual General Meeting, Jun 09, 2022 May 02
Price target decreased to US$7.67 Apr 27
Sientra (NASDAQ:SIEN) Is Carrying A Fair Bit Of Debt Apr 16
Consensus EPS estimates fall by 31% Mar 30
Price target decreased to US$10.60 Mar 24
Sientra, Inc. Provides Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021 Jan 12
Is Sientra (NASDAQ:SIEN) Using Too Much Debt? Jan 06
Third quarter 2021 earnings released: US$0.097 loss per share (vs US$0.12 loss in 3Q 2020) Nov 12
Lead Independent Director Nicholas Simon has left the company Sep 10
Sientra, Inc. Increases Earnings Guidance for the Full Year 2021 Aug 12
Second quarter 2021 earnings released: US$0.32 loss per share (vs US$0.68 loss in 2Q 2020) Aug 12
1315 Capital, LLC completed the acquisition of miraDry business of Sientra, Inc. (NasdaqGS:SIEN). Jun 12
Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: SIEN.Q şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.
Büyüyen Temettü: SIEN.Q şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.
Piyasaya Karşı Temettü Getirisi Project Sage Oldco Piyasaya Karşı Temettü Getirisi
SIEN.Q temettü verimi piyasa ile karşılaştırıldığında nasıldır? Segment Temettü Verimi Şirket (SIEN.Q) n/a Pazarın Alt %25'i (US) 1.3% Pazarın En İyi %25'i (US) 4.3% Sektör Ortalaması (Medical Equipment) 1.7% Analist tahmini (SIEN.Q) (3 yıla kadar) n/a
Önemli Temettü: SIEN.Q şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.
Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, SIEN.Q şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: SIEN.Q şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranı nı hesaplamak üzere yeterli veri yok.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: SIEN.Q herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.
Güçlü temettü ödeyen şirketleri keşfedin Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
